Literature DB >> 17034663

Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease.

Xuezhi Hong1, Huiqing Tang, Limao Wu, Lianda Li.   

Abstract

The aim of this investigation was to evaluate the efficacy of Alisma orientalis methanolic extract (AOME) on the experimental nonalcoholic fatty liver disease (NAFLD) induced by high-fat diet. Rats were fed with high-fat diet for six weeks and then gavaged the AOME for another six weeks. Typical pathological symptoms of NAFLD occurred in the high-fat diet rats. Administration with the AOME (150,300 and 600 mg kg (-1)) markedly decreased the serum and liver lipids; the high level of fasting serum glucose was reduced and insulin resistance was improved. The AOME treatment was also helpful in preventing the oxidative stress by lessening lipid peroxidation and activating antioxidant enzymes. Markers of the liver injury, aminotransferase abnormalities and hepatomegaly were improved and morphological changes, such as liver steatosis, mixed inflammation and collagen deposition, were lessened in rats treated with the AOME. These results suggested that the AOME showed hepatoprotective effects on NAFLD and may be a potential clinical application for treatment of this chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17034663     DOI: 10.1211/jpp.57.10.0013

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  15 in total

Review 1.  Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease.

Authors:  Hui Dong; Fu-Er Lu; Li Zhao
Journal:  Chin J Integr Med       Date:  2012-02-05       Impact factor: 1.978

2.  The Compatibility of Alisma and Atractylodes Affects the Biological Behaviours of VSMCs by Inhibiting the miR-128-5p/p21 Gene.

Authors:  Wei Wei; Yang Jie Zhou; Ju Lian Shen; Lu Lu; Xin Ru Lv; Tao Tao Lu; Pei Tao Xu; Xie Hua Xue
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-07       Impact factor: 2.650

3.  Effects of Rhizoma Alismatis extract on biochemical indices and adipose gene expression in oleic acid-induced hepatocyte injury in Jian carp (Cyprinus carpio var. Jian).

Authors:  Jinliang Du; Rui Jia; Li-Ping Cao; Weidong Ding; Pao Xu; Guojun Yin
Journal:  Fish Physiol Biochem       Date:  2018-03-30       Impact factor: 2.794

4.  Hugan Qingzhi Exerts Anti-Inflammatory Effects in a Rat Model of Nonalcoholic Fatty Liver Disease.

Authors:  WaiJiao Tang; Lu Zeng; JinJin Yin; YuFa Yao; LiJuan Feng; XiaoRui Yao; XiaoMin Sun; BenJie Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-14       Impact factor: 2.629

5.  Treatment of rats with Jiangzhi Capsule improves liquid fructose-induced fatty liver: modulation of hepatic expression of SREBP-1c and DGAT-2.

Authors:  Yuanyang Zhao; Yongquan Pan; Yifan Yang; Robert Batey; Jianwei Wang; Yuhao Li
Journal:  J Transl Med       Date:  2015-06-02       Impact factor: 5.531

6.  In Vitro Screening for Antihepatic Steatosis Active Components within Coptidis Rhizoma Alkaloids Extract Using Liver Cell Extraction with HPLC Analysis and a Free Fatty Acid-Induced Hepatic Steatosis HepG2 Cell Assay.

Authors:  Hui Fan; Yuan-Yuan Chen; Wei-Jian Bei; Lai-You Wang; Bao-Tian Chen; Jiao Guo
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-18       Impact factor: 2.629

Review 7.  Herbal medicines for the treatment of nonalcoholic steatohepatitis: current scenario and future prospects.

Authors:  Ravirajsinh Jadeja; Ranjitsinh V Devkar; Srinivas Nammi
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-03       Impact factor: 2.629

8.  Growth performance, meat yield, oxidative stability, and Fatty Acid composition of meat from broilers fed diets supplemented with a medicinal plant and probiotics.

Authors:  Md Elias Hossain; Gwi Man Kim; Sung Ki Lee; Chul Ju Yang
Journal:  Asian-Australas J Anim Sci       Date:  2012-08       Impact factor: 2.509

9.  Therapeutic Effect of the Tuber of Alisma orientale on Lipopolysaccharide-Induced Acute Lung Injury.

Authors:  Kyun Ha Kim; Min Jung Kwun; Jun-Yong Choi; Kyung-Seop Ahn; Sei-Ryang Oh; Yong Gyu Lee; John W Christman; Ruxana T Sadikot; Chang Woo Han; Myungsoo Joo
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-25       Impact factor: 2.629

10.  Evaluation of a crataegus-based multiherb formula for dyslipidemia: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Miao Hu; Weiwei Zeng; Brian Tomlinson
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-16       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.